In Vitro Diagnostics Dominates China Medical Devices Market, According to GBI Research

22 Nov 2012 • by Natalie Aster

China’s huge and increasingly elderly population, some remotely situated in rural areas, will be provided with strong healthcare infrastructure, states the new report, ''Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth'' by GBI Research.
/ 

Report Details:

Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth
Published: November, 2012
Pages: 131
Price: US$ 3.150,00

The rising incidence of chronic and infectious diseases in this vast country serves to benefit both patients and medical device companies, who may supply China’s government to meet their new healthcare reforms.

The healthcare reform initiative known as ‘Opinions on Deepening the Health Care System Reform’, or the ‘New Health Care Reform Plan’, is being implemented by the Chinese State Council and the Communist Party of China (CPC) Central Committee, and represents a major driving factor for the healthcare sector in China. The reforms aim to provide health services for both the urban and rural population.

Healthcare infrastructure improvements are expected to drive market growth for both international and domestic companies, due to improved affordability and accessibility to healthcare services within a growing number of hospitals. New insurance policies aiming to increase the reimbursement ratio for a number of diseases will also lead to an expanding patient base.

Chronic diseases go hand in hand with elderly populations and demand significant medical support. An increasing life expectancy is leading to a growing incidence of ophthalmic diseases, as the elderly population has a high percentage of patients suffering from cataracts, with a large number of cases being added annually. Despite the large patient pool, China displays a low Cataract Surgery Rate (CSR), due to high costs, limited public awareness, and a lack of facilities in rural areas. However, the implementation of government-backed insurance schemes will increase reimbursement for medical treatment, and a significant demand is expected to be seen for ophthalmic surgery devices.

Infectious diseases can also become more common in developing countries, as populations become more urbanized and live in closer quarters to one another. China’s medical devices market is dominated by In Vitro Diagnostics (IVD) and driven by a large patient pool that requires large volumes of tests – especially amidst rising cases of infectious diseases, which claimed nearly 15,802 lives in 2011. Improving the affordability of IVD products in China through new healthcare reforms is expected to boost the market.

More information can be found in the report “Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth” by GBI Research.

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com